<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>HPC药闻药事 | wechat-feeds</title><link>http://MzA3NTQyMTk5Mg.favicon.privacyhide.com/favicon.ico</link><description>传递医药资讯 分享法规知识</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 26 Feb 2021 11:48:48 +0800</pubDate><image><url>http://MzA3NTQyMTk5Mg.favicon.privacyhide.com/favicon.ico</url><title>HPC药闻药事 | wechat-feeds</title><link>http://MzA3NTQyMTk5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>关注杜丨单药疗法PD-1抑制剂获FDA批准，治疗晚期NSCLC</title><link>https://mp.weixin.qq.com/s/BozRBspEfrQPnsOcpXeHLA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/sIlIaqTBgzHav0o9beXEwqQ7asLsE4TRLE62iaWqFlXYkicyyv2NJicI1H3eMhk0j580XIYZhk5UvfIViarvAic1hww/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Libtayo在美国获得第三个批准。]]></content:encoded><pubDate>Fri, 26 Feb 2021 11:19:38 +0800</pubDate></item><item><title>关注杜丨心衰患者福音！FDA批准诺华Entresto扩大适用范围</title><link>https://mp.weixin.qq.com/s/fXZlRHRdXc-G5N8P0L8Aug</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/sIlIaqTBgzG65QY5SFO8X0snK86JlC7EFIag3NOoXCrWLp1d2W11UGrDHYvAMUBMTA8gSGc4dKtIHwOWBRanPg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>FDA首次批准治疗射血分数保留性心力衰竭的药物。]]></content:encoded><pubDate>Tue, 23 Feb 2021 09:47:37 +0800</pubDate></item><item><title>关注杜丨治疗狼疮性肾炎的第一个口服药物LUPKYNIS™获FDA批准</title><link>https://mp.weixin.qq.com/s/VSeehwyOW3J347DWsPtClg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/sIlIaqTBgzHsXNAgd2QsXGl1qH7ev3rCr7fcZW42pjhTwhUibSvRIBZk6teeWdNDV1coT3vbPibJSjd11PE4H3Sg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>第一个治疗狼疮性肾炎的联合免疫抑制口服疗法，现已可以用于美国患者。]]></content:encoded><pubDate>Tue, 26 Jan 2021 10:57:51 +0800</pubDate></item><item><title>分享图片</title><link>https://mp.weixin.qq.com/s/U9uqwfMTExlG-LpHhG1ATw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/sIlIaqTBgzEDoZLp9QIyKyB9nFnicdKmQ141PSCUK5Bm0yL3OkiadVWeuxE5OM4FzMXLaEYolgQiaEBHWaaQFcsCg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Thu, 31 Dec 2020 21:30:55 +0800</pubDate></item><item><title>关注杜︱疫苗终于来了！FDA批准的第一个新冠疫苗EUA</title><link>https://mp.weixin.qq.com/s/U12H8lDRNmQQZPQGo0AxeA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/sIlIaqTBgzFO5Cd7SMzEzdC50jeA8BzwATcrto1zibGNjichz2zHnUQXgeZZrnqIzVTpRQhbhftScjzFyeUju1zQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>关注杜解析FDA在紧急使用授权（EUA）的条件下批准了辉瑞/BioNTech的新冠疫苗。]]></content:encoded><pubDate>Wed, 16 Dec 2020 10:12:40 +0800</pubDate></item><item><title>埃格林医药正式启动中/重度新冠肺炎口服治疗药的临床一期试验</title><link>https://mp.weixin.qq.com/s/_klf0BdZpORJJ1ULWec3PA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/sIlIaqTBgzEyv241cmV6ysCia61TKyHG0GHth0S1G4YeZG6OJ8SB7qB95LicSGQ6ZicBWibulomOghhthneH5ceAtw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>EG-009是埃格林医药的十大研发管线之一，将用于治疗新冠病毒引发的细胞因子风暴。]]></content:encoded><pubDate>Wed, 16 Dec 2020 10:12:40 +0800</pubDate></item></channel></rss>